Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

The science of megestrol acetate delivery: potential to improve outcomes in cachexia.

Femia RA, Goyette RE.

BioDrugs. 2005;19(3):179-87. Review.

PMID:
15984902
2.
4.
5.

Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.

Loprinzi CL, Bernath AM, Schaid DJ, Malliard JA, Athmann LM, Michalak JC, Tschetter LK, Hatfield AK, Morton RF.

Oncology. 1994 Oct;51 Suppl 1:2-7.

PMID:
7970505
6.

Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patients.

Graham KK, Mikolich DJ, Fisher AE, Posner MR, Dudley MN.

J Acquir Immune Defic Syndr. 1994 Jun;7(6):580-6.

PMID:
8176641
7.

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.

Vadell C, Seguí MA, Giménez-Arnau JM, Morales S, Cirera L, Bestit I, Batiste E, Blanco R, Jolis L, Boleda M, Antón I.

Am J Clin Oncol. 1998 Aug;21(4):347-51.

PMID:
9708631
8.

Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.

Yeh SS, Lovitt S, Schuster MW.

J Nutr Health Aging. 2009 May;13(5):448-54.

PMID:
19390752
9.

Megestrol acetate for the treatment of anorexia-cachexia syndrome.

Berenstein EG, Ortiz Z.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004310. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD004310.

PMID:
15846706
10.

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.

Tomíska M, Tomisková M, Salajka F, Adam Z, Vorlícek J.

Neoplasma. 2003;50(3):227-33.

PMID:
12937858
11.
12.

Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome.

Pascual López A, Roqué i Figuls M, Urrútia Cuchi G, Berenstein EG, Almenar Pasies B, Balcells Alegre M, Herdman M.

J Pain Symptom Manage. 2004 Apr;27(4):360-9. Review.

PMID:
15050664
13.

Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.

Von Roenn JH, Murphy RL, Wegener N.

Semin Oncol. 1990 Dec;17(6 Suppl 9):13-6.

PMID:
2259923
14.

Clinical management of anorexia and cachexia in patients with advanced cancer.

Bruera E.

Oncology. 1992;49 Suppl 2:35-42. Review.

PMID:
1461626
15.

Studies of high-dose megestrol acetate: potential applications in cachexia.

Aisner J, Tchekmedyian NS, Tait N, Parnes H, Novak M.

Semin Oncol. 1988 Apr;15(2 Suppl 1):68-75. Review.

PMID:
3285486
16.

[Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].

Krznarić Z, Juretić A, Samija M, Dintinjana RD, Vrdoljak E, Samarzija M, Kolacek S, Vrbanec D, Prgomet D, Ivkić M, Zelić M; Croatian Society of Parenteral and Enteral Nutrition, Croation Society of Oncology, Croation society of Medical Oncology, Croation Medical Association..

Lijec Vjesn. 2007 Dec;129(12):381-6. Croatian.

PMID:
18383739
18.

Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.

Mantovani G, Macciò A, Lai P, Massa E, Ghiani M, Santona MC.

Semin Oncol. 1998 Apr;25(2 Suppl 6):45-52. Review.

PMID:
9625383
19.

Megestrol acetate for anorexia and cachexia.

Loprinzi CL, Johnson PA, Jensen M.

Oncology. 1992;49 Suppl 2:46-9.

PMID:
1461628
20.

Megestrol acetate for geriatric anorexia/cachexia.

Haren MT, Kim MJ, Kevorkian RT.

J Am Geriatr Soc. 2006 Jan;54(1):172-3; author reply 173-4. No abstract available.

PMID:
16420220

Supplemental Content

Support Center